COMPARATIVE CLINICAL STUDY OF BHALLATAKADI CHURNA AND ERANDA SNEHA IN THE MANAGEMENT OF AMAVATA WITH SPECIAL REFERENCE TO RHEUMATOID ARTHRITIS

Abstract

Amavata is most crippling joint disease. With the passage of time most of the dietary habits, changing lifestyle and environment have been contributing number of diseases like Amavata which have become a challenge to the human race. Management of this disease is merely insufficient in other systems of medicine and patients are continuously looking for treatment from Ayurveda to overcome this challenge. The aim of this study was to evaluate the efficacy of study drugs in the management of Amavata and their effect on Rheumatoid Factor (RA) Factor. In the present clinical study, 60 patients of amavata were registered from the out patient department and indoor patient department of Yashwant Dharmarth Hospital, Kodoli, Kolhapur, Maharashtra, India. The patients in group I (20 patients) were given Bhallatakadi Churna, patients in group II (20 patients) were given Eranda tail and the patients in group III (20 patients) were given Bhallatakadi Churna along with Eranda tail. Patients treated with group III had better relief in most of lakshanas of disease and also improvement in objective criteria like RA Factor, ESR and C reactive proteins. The improvement was statistically significant in all three groups, but comparatively group III shown more significant relief.